HILPDA and hepatocellular carcinoma: Mechanistically, HIG2 increases IL-10 expression via AMPK/CREB signaling, and the secreted IL-10 inhibits the cytotoxicity of NK cells through the STAT3 signaling pathway, thereby promoting the recurrence and metastasis of HCC.